Preprint

Review

Repurposing of FDA Approved Drugs as COVID-19 Therapeutics: Safety Concerns and Contraindications of Drugs in Clinical Trials

This version is not peer-reviewed.

Ravinder Naik Dharavath^*,

Priya Badyal,Nitin Rawat,Tanzeer Kaur,

Shweta Sharma,Mahendra Bishnoi,

Kanwaljit Chopra

Ravinder Naik Dharavath^*,

Priya Badyal,Nitin Rawat,Tanzeer Kaur,

Shweta Sharma,Mahendra Bishnoi,

Kanwaljit Chopra

This version is not peer-reviewed.

Downloads

949

Views

930

Comments

1

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

MDPI Initiatives

Important Links

Subscribe

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

© 2025 MDPI (Basel, Switzerland) unless otherwise stated

Disclaimer

© 2025 MDPI (Basel, Switzerland) unless otherwise stated